Scarica l'app Stockscreener
54.76
4.23%
2.22
Dopo l'orario di chiusura:
54.25
-0.51
-0.93%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HIMS Giù?
Forum
Previsione
Precedente Chiudi:
$52.54
Aprire:
$53.61
Volume 24 ore:
27.01M
Relative Volume:
0.94
Capitalizzazione di mercato:
$11.92B
Reddito:
$1.78B
Utile/perdita netta:
$164.40M
Rapporto P/E:
79.36
EPS:
0.69
Flusso di cassa netto:
$236.51M
1 W Prestazione:
-7.37%
1M Prestazione:
+13.12%
6M Prestazione:
+110.70%
1 anno Prestazione:
+210.08%
Intervallo 1D:
$52.70
$54.80
Intervallo di 1 settimana:
$52.51
$59.27
Portata 52W:
$17.36
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Nome
Hims Hers Health Inc
Settore
Telefono
415-851-0195
Indirizzo
2269 CHESTNUT ST, SAN FRANCISCO
Confronta HIMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
54.76 | 11.88B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
145.36 | 64.89B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.55 | 46.11B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
8.79 | 39.85B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.96 | 22.95B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
453.28 | 20.49B | 2.99B | 1.21B | 1.13B | 25.06 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-23 | Downgrade | Needham | Buy → Hold |
| 2025-06-04 | Reiterato | Needham | Buy |
| 2025-04-29 | Downgrade | TD Cowen | Buy → Hold |
| 2025-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Downgrade | Citigroup | Neutral → Sell |
| 2025-01-07 | Iniziato | BTIG Research | Buy |
| 2024-12-17 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-08-22 | Iniziato | Needham | Buy |
| 2024-08-09 | Downgrade | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Downgrade | Citigroup | Buy → Neutral |
| 2024-04-16 | Downgrade | Jefferies | Buy → Hold |
| 2024-04-10 | Iniziato | Canaccord Genuity | Buy |
| 2024-02-28 | Aggiornamento | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-07 | Iniziato | Imperial Capital | In-line |
| 2023-07-28 | Iniziato | TD Cowen | Outperform |
| 2023-04-11 | Iniziato | Robert W. Baird | Neutral |
| 2023-02-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-08 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-11-08 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-07-15 | Iniziato | SVB Leerink | Underperform |
| 2022-04-14 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-10 | Iniziato | Deutsche Bank | Hold |
| 2021-12-02 | Iniziato | Jefferies | Hold |
| 2021-11-11 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Iniziato | BofA Securities | Neutral |
| 2021-05-20 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Iniziato | Truist | Hold |
| 2021-03-09 | Iniziato | Credit Suisse | Neutral |
| 2021-03-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-02-17 | Iniziato | Citigroup | Neutral |
| 2021-02-12 | Iniziato | Piper Sandler | Neutral |
| 2021-02-08 | Iniziato | Tigress Financial | Buy |
Mostra tutto
Hims Hers Health Inc Borsa (HIMS) Ultime notizie
Hims & Hers Health Stock (HIMS) Opinions on Recent Price Surge - Quiver Quantitative
Why Hims & Hers Stock Slipped Today - MSN
HIMS Stock Dips Following Executive Transition Announcement - GuruFocus
U.S. Indexes Ended Friday Mixed As Rigetti Computing Led, Hims & Hers Health Lagged - Barron's
$HIMS stock is down 8% today. Here's what we see in our data. - Quiver Quantitative
Berger Montague Investigates Hims & Hers Health Inc. (NYSE: HIMS) Board of Directors for Potential Breaches of Fiduciary Duties - Weatherford Democrat
Hims & Hers Expands Health Access Through Subscription Revenue Model - Yahoo Finance
Evaluating Hims & Hers Health (HIMS) Valuation After 39% Share Price Surge in the Past Month - Yahoo Finance
Hims & Hers Health names new COO - Seeking Alpha
Hims & Hers Health Announces COO Transition - TipRanks
Hims & Hers Health says Nader Kabbani to step into advisory role on November 2SEC filing - MarketScreener
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know - The Globe and Mail
How Novo Nordisk Gave Up Its Weight-Loss Gains - Bloomberg.com
OMCL or HIMS: Which Is the Better Value Stock Right Now? - Yahoo Finance
BofA Securities maintains Underperform rating on Hims and Hers stock - Investing.com
Buy HIMS Stock At $56? - Forbes
Hers Health Inc. stock appeals to dividend seekersJuly 2025 Outlook & Daily Entry Point Alerts - newser.com
The Secret to Finding the Next Amazon Is Hiding in Plain Sight - The Motley Fool
Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Wait For A Dip To Buy Hims & Hers Health Stock - Trefis
FDA takes aim at Hims & Hers, weight loss drugs in new advertising blitz - WFMJ.com
Hims & Hers Health, Inc. (HIMS) Laps the Stock Market: Here's Why - Yahoo Finance
Notable Monday Option Activity: HIMS, AMBC, EXE - Nasdaq
Hims & Hers Health Stock Skyrockets amid Weight-Loss Mania – But FDA Scrutiny Looms! - ts2.tech
Top Healthcare Stocks To Follow TodaySeptember 26th - MarketBeat
Healthcare Stocks To Follow TodaySeptember 25th - MarketBeat
Dakota Wealth Management Takes Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Not Nearly Enough People Are Talking About Chewy Stock - The Globe and Mail
Promising Medical Stocks To Keep An Eye OnSeptember 28th - MarketBeat
Top Healthcare Stocks To Add to Your WatchlistSeptember 27th - MarketBeat
Promising Medical Stocks Worth WatchingSeptember 27th - MarketBeat
FDA takes aim at Hims & Hers weight loss drugs in new advertising blitz - Hays Post
3 Healthcare Stocks Using AI to Drive Growth - MarketBeat
Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 33% Share Price Bounce - simplywall.st
Hims & Hers Health Inc. Class A (HIMS) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Hims & Hers: Navigating GLP Controversy With AplombBut Risks Warrant Hold Rating (HIMS) - Seeking Alpha
Hims & Hers Health (NYSE:HIMS) Shares Up 5.7%Here's Why - MarketBeat
Best Medical Stocks To Add to Your WatchlistSeptember 26th - MarketBeat
Hims & Hers: Growth Meets FDA Scrutiny And Tariff Risks (NYSE:HIMS) - Seeking Alpha
Hims & Hers Powers YieldMax's Latest Options-Based Income ETF - Benzinga
HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment? - The Globe and Mail
Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
1 Momentum Stock with Competitive Advantages and 2 We Find Risky - The Globe and Mail
Michael Chi Sells 2,100 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
2 Volatile Stocks Worth Investigating and 1 That Underwhelm - The Globe and Mail
Oluyemi Okupe Sells 23,584 Shares of Hims & Hers Health (NYSE:HIMS) Stock - MarketBeat
Promising Medical Stocks To Watch TodaySeptember 24th - MarketBeat
Healthcare Stocks To ResearchSeptember 24th - MarketBeat
Kuehn Law Encourages Investors of Hims & Hers Health, Inc. to Co - GuruFocus
Kuehn Law Encourages Investors of Hims & Hers Health, Inc. to Contact Law Firm - PR Newswire
Hims and Hers Weight Loss Success - wspa.com
Hims Hers Health Inc Azioni (HIMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Hims Hers Health Inc Azioni (HIMS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chi Michael | Chief Commercial Officer |
Oct 01 '25 |
Sale |
56.00 |
250 |
14,000 |
291,439 |
0.59%
0.10%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):